Description
RPMI1640Mediumwasoriginallydevelopedtoculturehumanleukemiccellsins
USPensionandasamonolayer.RoswellParkMemorialInstitute(RPMI)1640Mediumhassincebeenfoundsuitableforavarietyofmammaliancells,includingHeLa,Jurkat,MCF-7,PC12,PBMC,astrocytes,andcarcinomas.WeofferavarietyofRPMI1640Mediummodificationsforarangeofcellcultureapplications.Findtherightformulationusingthemediaselectortool.
ThisRPMIismodifiedasfollows:With | Without |
•L-glutamine | •Glucose |
Thecompleteformulationisavailable.
UsingRPMIRPMI1640Mediumisuniquefromothermediabecauseitcontainsthereducingagentglutathioneandhighconcentrationsofvitamins.RPMI1640Mediumcontainsbiotin,vitaminB
12,andPABA,whicharenotfoundinEagle"sMinimalEssentialMediumorDulbecco"sModifiedEagleMedium.Inaddition,thevitaminsinositolandcholinearepresentinveryhighconcentrations.RPMI1640Mediumcontainsnoproteins,lipids,orgrowthfactors.Therefore,RPMI1640Mediumrequiressupplementation,commonlywith10%FetalBovineSerum(FBS).RPMI1640Mediumusesasodiumbicarbonatebuffersystem(2.0g/L),andthereforerequiresa5–10%CO
2environmenttomaintainphysiologicalpH.
cGMPmanufacturingandqualitysystemRPMI1640MediumismanufacturedatacGMP-compliantfacilitylocatedinGrandIsland,NewYork.ThefacilityisregisteredwiththeFDAasamedicaldevicemanufacturerandiscertifiedtoISO13485standards.
ForResearchUseOnly.Notforuseindiagnosticprocedures.